About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Company News CSR News We have started the construction of a photovoltaic farm in Starogard Gdański20 October 2022As the largest Polish pharmaceutical company, we want to help people live a healthy life in a healthy world, and care for the climate and… read more
Company News The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!16 August 2022The jurors appreciated the Leonardo program primarily for its creativity, ability to build commitment and innovative communication. The International Business Awards® is the world’s largest… read more
Company News Polpharma partners with Pikralida biopharmaceutical start-up19 July 2022The cooperation involves manufacturing of the drug substance of the clinical candidate PKL-021, needed to support the preclinical research program and the production of an… read more
Company News CSR News Polpharma’s Compliance Team awarded by the Compliance Institute06 June 2022The aim of the “Compliance Awards” competition is to increase market awareness and reward particular achievements in the area of compliance management, both for individuals… read more
Company News CSR News Polpharma received another CSR Golden Leaf06 June 2022Polpharma received this highest award for the eighth time. The Golden Leaf is awarded to companies for which sustainable development is a key element of strategic… read more
